e-learning
resources
Virtual 2020
Pre-Congress Content
Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis
B. Pattnaik (New Delhi, India), S. Pb (New Delhi, India), S. Mittal (New Delhi, India), A. Mohan (New Delhi, India), A. Agrawal (New Delhi, India), R. Guleria (New Delhi, India), K. Madan (New Delhi, India)
Source:
Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session:
Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session type:
E-poster session
Number:
1083
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Pattnaik (New Delhi, India), S. Pb (New Delhi, India), S. Mittal (New Delhi, India), A. Mohan (New Delhi, India), A. Agrawal (New Delhi, India), R. Guleria (New Delhi, India), K. Madan (New Delhi, India). Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis. 1083
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
Diagnosing Pulmonary Tuberculosis by Pooling Induced Sputum
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Inflammatory markers in the exhaled breath condensate from patients with pulmonary sarcoidosis: comparison with BALF
Source: Eur Respir J 2006; 28: Suppl. 50, 353s
Year: 2006
Changes in PH of exhaled breath condensate after specific inhalation challenge test, in patients with hypersensitivity pneumonitis
Source: International Congress 2014 – ILDs 3
Year: 2014
Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference?
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017
Pneumomediastinum following EBUS-TBNA in patients with Pulmonary Fibrosis
Source: International Congress 2017 – EBUS
Year: 2017
Serum levels of sestrin 2 in patients with sarcoidosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Exhaled breath condensate pH in assessment of childhood asthma control
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Exhaled breath: Non-invasive diagnosis of ventilator-associated pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015
Comparison of eicosanoids in sputum, bronchoalveolar lavage and exhaled breath condensate
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Exhaled breath analysis using eNose technology in patients with sarcoidosis
Source: Virtual Congress 2020 – Sarcoidosis: from genetics to epidemiology
Year: 2020
Exhaled breath condensate pH in exercise-induced bronchoconstriction
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Detection of exosomal miRNA in pulmonary sarcoidosis
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Inflammatory markers in exhaled breath condensate in bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 707s
Year: 2004
Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Exhaled particles as markers of small airways inflammation in asthmatic subjects
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Exhaled Breath Analysis for the Diagnosis of Obstructive Sleep Apnea
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Year: 2018
Exhaled breath condensate hydrogen peroxide in obstructive airways disease
Source: International Congress 2014 – Airway biomarkers
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept